630.40002 EUR
0.2
0.03%
Last update Dec 12, 3:36 PM CET
Main market
Day range
630.40002
635.20001
Previous close
630.20001
Open
635.20001
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
630.40
0.20
0.03%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 12.1B 13.1B 12.2B 16.1B
Cost of revenue 1.7B 1.8B 1.6B 2.4B
Gross profit 10.4B 11.3B 10.6B 13.6B
Operating expense
Research & development 4.5B 4.4B 3.6B 2.9B
Selling general and admin 2.5B 2.6B 2.1B 1.8B
Other operating expenses 45.5M -2.1M -89.9M -45.6M
Operating income 3.4B 4.2B 5.0B 9.0B
Non operating interest income
Income 606.3M 495.9M 160.1M 45.8M
Expense 47.0M 73M 59.4M 57.3M
Other income expense 113.3M -456.8M -235.9M 342.5M
Pretax income 4.1B 4.2B 4.9B 9.3B
Tax provision 313.0M 245.7M 520.4M 1.3B
Net income 3.8B 4.0B 4.3B 8.1B
Basic EPS 40.9 37.1 40.5 76.4
Diluted EPS 38.3 34.8 38.2 72.0
Basic average shares 92.0M 111.0M 111.5M 110.0M
Diluted average shares 92.0M 111.0M 111.5M 110.0M
EBITDA 4.4B 5.1B 5.5B 9.3B
Net income from continuing op. 3.8B 4.0B 4.3B 8.1B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 11 hours 36 minutes

10:23
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).